Crescent Grove Advisors’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-7,999
Closed -$403K – 167
2019
Q3
$403K Sell
7,999
-102
-1% -$5.21K 0.08% 96
2019
Q2
$437K Sell
8,101
-372
-4% -$19.4K 0.08% 92
2019
Q1
$451K Sell
8,473
-2,770
-25% -$144K 0.09% 93
2018
Q4
$533K Buy
11,243
+2,815
+33% +$147K 0.11% 93
2018
Q3
$490K Sell
8,428
-3,200
-28% -$177K 0.11% 83
2018
Q2
$637K Buy
11,628
+864
+8% +$42.9K 0.16% 73
2018
Q1
$513K Buy
+10,764
New +$539K 0.13% 78

Other funds holding NTR

Crescent Grove Advisors's NTR Position: Q4 2019 in Review

Crescent Grove Advisors sold out of Nutrien (NTR) in Q4 2019, closing a stake of 7,999 shares — an estimated $403K sold.

Crescent Grove Advisors first reported a position in NTR in Q1 2018 and held it in 7 quarters. The position peaked at $637K in Q2 2018. 549 funds tracked by Wall St. Rank hold NTR as of Q4 2019.

  • Crescent Grove Advisors reported no remaining Nutrien position as of Q4 2019 after selling out during the quarter.
  • Crescent Grove Advisors sold 7,999 Nutrien shares in Q4 2019, an estimated $403K.
  • Crescent Grove Advisors first reported a position in Nutrien in Q1 2018 and held it in 7 quarters.
  • Crescent Grove Advisors's Nutrien position peaked at $637K in Q2 2018.
  • 549 funds tracked by Wall St. Rank held Nutrien as of Q4 2019.

Based on Crescent Grove Advisors's 13F filing for Q4 2019, filed 3 Feb 2020.